About Kintsugi
Kintsugi is a mental health technology company that leverages voice biomarker AI to identify, triage, and facilitate care for depression and anxiety. The company's flagship product, Kintsugi Voice, analyzes acoustic features of speech—including pitch, intonation, tone, and pauses—to detect signs of mental health conditions without relying on what is said, making it language-agnostic and privacy-preserving. The platform integrates seamlessly into existing clinical workflows, call centers, and telehealth systems through an API-first approach, enabling real-time screening and triage. Kintsugi's mission is to scale access to mental healthcare for all, addressing the critical gap where 60% of patients with mental health conditions fall through the cracks and 30-40% remain undiagnosed. The company recognizes that clinical depression is present in 80% of chronic health conditions and that undiagnosed depression increases healthcare costs by 2-8 times. By providing objective, quantifiable mental health screening tools, Kintsugi helps clinicians who currently only note mental health conditions 33.6% of the time according to a global Lancet study. The company offers three complementary products: Kintsugi Voice for enterprise identification and triage, Kintsugi Connect for routing individuals to appropriate mental health resources, and the Kintsugi App for personal voice journaling and self-care. Kintsugi works with payers, health systems, providers, and digital health companies to improve member outcomes, close care gaps, and reduce costs through early detection and intervention. The company has published peer-reviewed research in the Annals of Family Medicine and has been recognized by Gartner as a Cool Vendor in AI Governance and Responsible AI, and by CB Insights as one of the Digital Health 150.
Mission & Story
Mission
We're on a mission to scale access to mental healthcare for all.
Founding Story
Founded by Grace Chang (Founder/CEO). The company name 'Kintsugi' references the Japanese art of repairing broken pottery with gold, symbolizing the beauty in healing and transformation.
Clinical Focus
Medical conditions and clinical areas addressed by Kintsugi.
Who It Serves
Milestones & Awards
Recent Milestones
Peer-reviewed study published in Annals of Family Medicine (January 2025). Named to Forbes 50 AI. Integration with Pega platform announced. $30M gift to global mental health community announced (February 2026 - future date, likely aspirational).
Awards & Recognition
Gartner Cool Vendor 2022 in AI Governance and Responsible AI. Frost & Sullivan 2022 North American Vocal Biomarkers for Mental Health Technology Innovation Leadership Award. CB Insights Digital Health 150. BuiltIn Best Places to Work 2023. Fierce Healthcare Fierce 15 of 2023. Forbes 50 AI.
Key Partnerships
Social & Media
Follow on
Latest Updates
RE: The richness of rural education and practice
RE: Fall-Related Emergency Department Visits Among Adults with and without Intellectual and Developmental Disabilities or Cerebral Palsy
Specialty-Specific Barriers to Appointment Adherence in Gastroenterology: Implications for a Predictive Model
Beyond Voluntarism: The Need for Structural Frameworks in Rural Medical Education
RE: Proximal Intercessory Prayer for pain and anxiety
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 48 →
AbleTo
AI-powered mental health and digital therapeutics platform delivering behavioral health interventions and therapy support.
Akili
Akili Interactive creates FDA-authorized digital therapeutics delivered through video game experiences to treat cognitive impairments. Their flagship products include EndeavorRx, the first FDA-approved prescription video game for children with ADHD, and EndeavorOTC for adults with ADHD.
Alma
Alma is a mental health care platform that connects clients with therapists who accept insurance across all 50 states. The company supports both clients seeking affordable therapy and mental health providers with practice management tools and insurance credentialing.
Alto Neuroscience
Alto Neuroscience develops biology-driven precision medicines for neuropsychiatric conditions. The company uses brain biology measurements to predict clinical response and identify patients most likely to benefit from their drug candidates.
BeMe Health
BeMe is a mobile mental health platform designed specifically for teens and young adults. The app provides a safe space for mood tracking, personalized content, live 1:1 coaching, and crisis support to improve emotional well-being and mental health.
Big Health
Big Health provides FDA-cleared digital therapeutics delivering cognitive behavioral therapy (CBT) for insomnia and anxiety. Their prescription products, SleepioRx and DaylightRx, serve health systems, health plans, and employers with evidence-based mental health solutions backed by 100+ peer-reviewed publications.
Blueprint Health
Blueprint provides an AI-powered assistant for mental health therapists that automates clinical documentation, generates treatment plans, and delivers clinical support. The platform works alongside existing EHRs or as a standalone AI-native EHR with integrated scheduling, telehealth, billing, and insurance management.
Boulder Care
Boulder Care provides telehealth-based addiction treatment for substance use disorder (SUD), including opioid use disorder (OUD) and alcohol use disorder (AUD). The company delivers whole-person, coordinated outpatient care through a secure mobile app, including medication-assisted treatment (MAT) with Suboxone and other medications, supported by dedicated care teams.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.